Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.50
-$0.15-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 790.70K | 1.65M | 836.90K | 798.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.95M | 1.78M | 3.05M | 1.48M | 1.38M |
| Operating Income | -2.95M | -1.78M | -3.05M | -1.48M | -1.38M |
| Income Before Tax | -3.05M | -1.60M | -3.78M | -2.03M | -1.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.05M | -1.60M | -3.78M | -2.03M | -1.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.05M | -1.60M | -3.78M | -2.03M | -1.73M |
| EBIT | -2.95M | -1.78M | -3.05M | -1.48M | -1.38M |
| EBITDA | -2.95M | -1.78M | -3.05M | -1.48M | -1.38M |
| EPS Basic | -7.60 | -8.13 | -39.68 | -24.12 | -20.85 |
| Normalized Basic EPS | -4.75 | -5.08 | -19.89 | -15.16 | -12.52 |
| EPS Diluted | -7.60 | -10.01 | -39.68 | -24.12 | -20.85 |
| Normalized Diluted EPS | -4.75 | -5.08 | -19.89 | -15.16 | -12.52 |
| Average Basic Shares Outstanding | 402.00K | 196.50K | 95.40K | 84.20K | 83.00K |
| Average Diluted Shares Outstanding | 402.00K | 196.50K | 95.40K | 84.20K | 83.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |